TAG:
clinical testing
Beckman Coulter Positions Itself For Biotech Testing Continuum
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
CEO SUMMARY: Here’s a little-known side to diagnostics giant Beckman Coulter Inc. Its efforts to expand into the fields of biomedical R&D and clinical research is a strategic shift designed to give it early access to promising technology that could be introduced into the clinical di…
Quest & LabCorp Show Gains In Mid-Year Financial Reports
By R. Lewis Dark | From the Volume VIII No. 12 – September 4, 2001 Issue
FOR THE FIRST SIX MONTHS OF 2001, improved pricing for lab testing services was the strongest contributor to revenue growth at both Laboratory Corporation of America and Quest Diagnostics Incorporated. One important consequence of this development is that competing …
Market Changes Lead LabCorp To Follow New Strategic Direction
By Robert Michel | From the Volume VIII No. 4 – March 19, 2001 Issue
CEO SUMMARY: When formed in 1995, Laboratory Corporation of America faced a financially-hostile marketplace for lab testing services. However, strategic planning retreats in 1997 and 1999 were pivotal in redirecting this billion-dollar lab behemoth toward financial stability. During 2000,…
AmeriPath & InformDX Merging To Form Largest Anatomic Pathology Firm in U.S.
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
CEO SUMMARY: AmeriPath and InformDX shared several common elements in their respective business strategies. Both companies believe that pathology services are best delivered at the local level and benefit from the support of a national organization. Both companies believe that physicians …
Specialty Labs Prepares For Public Stock Offering
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: Stock prices for public lab companies zoomed upwards through 2000. For this reason, executives at Specialty Laboratories, Inc. believe it is an auspicious time for their laboratory to bring an initial public offering (IPO) to market. Company officials recently filed a stock r…
Dr. Bruce Friedman Identifies Market Dynamics Driving Evolution of Lab Information Services
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Probably no one is better positioned to identify the evolution of laboratory information services than Bruce Friedman, M.D., Professor of Pathology at the University of Michigan Medical School in Ann Arbor. For almost 20 years, he has hosted the pre-eminent meeting in laborat…
Epitope, LabOne, CARESIDE, Quest, Structural Bioinformatics, UroCor
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
EPITOPE RAIDS LABONE FOR NEW PRESIDENT/CEO; READIES DRUGS OF ABUSE MARKET LAUNCH DURING THE YEAR 2000, Epitope, Inc., based in Portland, Oregon, plans to introduce a drugs of abuse test based on its patented OraSure® oral collection technology. To aid in this new product l…
HBOC, Abaton.com, Quest, Unilab, LabOne, Epitope
By Robert Michel | From the Volume VI No. 16 – November 22, 1999 Issue
MCKESSON HBOC ACQUIRES ABATON.COM IN MOVE TO WEB SERVICES IT WAS VALIDATION OF A PREDICTION made just weeks ago in THE DARK REPORT that web-based information management systems is the next major battleground in both healthcare and the clinical lab industry. McKesson HBOC an…
Quest Diagnostics and LabCorp Face an Evolving Marketplace
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
TWO OF THE THREE BLOOD BROTHERS reported continued improvement in their financial condition as second quarter earnings reports were made public. This news, however, was overshadowed by speculation about the failure of Quest Diagnostics Incorporated to consummate its purchase of …
Unilab, DIANON Systems, UroCor Report 1998 Financial Results
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
OPTIMISM REIGNS at California-based Unilab Corporation. Revenues are up, operating profits are increasing, and company officials are now talking about growth plans. For 1998, Unilab generated revenues of $217.4 million, compared to $214.0 million in 1997. …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized